Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guardian Pharmacy ServicesGRDN +0.48%42 EBIT per Share is $1.52 as of Jun. 2026. GuruFocus rates GRDN with a GF Score™ of 42/100. Among 523 Healthcare Providers & Services companies, Guardian Pharmacy Services ranks worse than 51.43% on this metric.
Guardian Pharmacy Services's EBIT per Share for the
three
months ended in Jun. 2026 was $0.47.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $1.52.
During the past 3 years, the average EBIT per Share Growth Rate was 10.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Guardian Pharmacy Services's EBIT per Share or its related term are showing as below:
GRDN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 4.9 Med: 8.95 Max: 13.7
Current: 10.4
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Guardian Pharmacy Services was 13.70% per year. The lowest was 4.90% per year. And the median was 8.95% per year.
GRDN's 3-Year EBIT Growth Rate is ranked worse than 51.43% of 523
companies
in the Healthcare Providers & Services industry
Industry Median: 11.8
vs GRDN: 10.40
Guardian Pharmacy Services (NYSE:GRDN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Guardian Pharmacy Services EBIT per Share Related Terms
Guardian Pharmacy Services EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardian Pharmacy Services (GRDN) has a EBIT per Share of $1.52 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Guardian Pharmacy Services and its competitors. According to the industry distribution chart, Guardian Pharmacy Services ranks #269 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 51.4%.
Is Guardian Pharmacy Services' EBIT per Share too high?
Guardian Pharmacy Services' current EBIT per Share is $1.52. The Healthcare Providers & Services industry median EBIT per Share is 11.80. Guardian Pharmacy Services' value of $1.52 is 87.1% below this industry median. Based on the distribution chart, Guardian Pharmacy Services ranks #269 out of 523 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' EBIT per Share compare to MD and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Guardian Pharmacy Services ranks #269 out of 523 companies for EBIT per Share. This places Guardian Pharmacy Services in the lower half of its industry. The industry median EBIT per Share is 11.80. Guardian Pharmacy Services' value of $1.52 is 87.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardian Pharmacy Services's current EBIT per Share of $1.52 is 87.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Guardian Pharmacy Services and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardian Pharmacy Services's current EBIT per Share is $1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current EBIT per Share of $1.52. The current EBIT per Share is $1.52 and 87.1% below the Healthcare Providers & Services industry median of 11.80. Guardian Pharmacy Services' overall GF Score™ is 42/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current EBIT per Share is $1.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score
Get the complete analysis for GRDN
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDN has been successfully added to your 
